China Universal Asset Management »

Aardvark Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $47k 3.5k 13.13

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Millennium Management
Silverarc Capital Management
Geode Capital Management
State Street Corporation
Two Sigma Investments
Centiva Capital
Cantor Fitzgerald, L. P.
Northern Trust
Superstring Capital Management
Goldman Sachs Group

View all funds holding Aardvark Therapeutics